Results 191 to 200 of about 9,747 (200)

XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a

Cancer Letters, 2021
Jingya Wang, Tao Sun, Zhixin Bie
exaly  

Selinexor. Exportin-1 (XPO1) inhibitor, Oncolytic

Drugs of the Future, 2014
null Riaz, W., null Burke, N., null Mahipal, A.   +2 more
openaire   +1 more source

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies

Journal of Cellular and Molecular Medicine, 2023
Elgilda Musi, Jumana Afaghani, Skye Montoya   +2 more
exaly  

CRM1/XPO1 (exportin)

2008
openaire   +1 more source

XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

Nature, 2016
Jimi Kim, Hyun Seok Kim, Jaime Rodriguez-Canales   +2 more
exaly  

Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia, 2018
Dan T Vogl, Msce, Ajai Chari
exaly  

KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology, 2014
Yun Zheng, Haibo Sun, H Phillip Koeffler
exaly  

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276

Leukemia, 2013
exaly  

CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma

Cancer Letters
Kelila Xin Ye Chai, Jason Yongsheng Chan, Choon Kiat Ong   +2 more
exaly  

Control of CRM1 (XPO1) by NOD2.

openaire   +1 more source